A Practical Guide for Diagnostic Investigations and Special Considerations in Patients With Huntington's Disease in...

Area of Science:

• Neurology
• Genetics
• Public Health

Background:

• Huntington's disease (HD) is a progressive neurodegenerative disorder with significant genetic and clinical heterogeneity.
• A tailored approach is needed for effective diagnosis and management within specific populations, such as the Korean population.
• Existing guidelines may not fully address the unique challenges and considerations for HD patients in Korea.

Purpose of the Study:

• To establish a comprehensive diagnostic and management framework for Huntington's disease (HD) specifically adapted for the Korean population.
• To provide guidance on genetic counseling, predictive testing, and reproductive options relevant to Korean families.
• To outline strategies for monitoring disease progression and managing comorbidities in Korean HD patients.

Main Methods:

• Review of current literature and guidelines on Huntington's disease diagnosis and management.
• Adaptation of international best practices to the Korean healthcare context.
• Inclusion of specific considerations for juvenile-onset, late-onset, and premanifest stages of HD.
• Discussion of diagnostic biomarkers, including laboratory tests, biofluids, and imaging.
• Emphasis on personalized symptom management and emerging therapeutic strategies.

Main Results:

• A structured diagnostic pathway for HD in Korea, incorporating genetic counseling and testing.
• Recommendations for assessing disease progression using biomarkers in premanifest and symptomatic HD.
• Guidance on managing associated comorbidities like diabetes mellitus, hypertension, and cardiovascular issues.
• Strategies for personalized symptom management, including pharmacotherapy, physical therapy, and nutritional support.
• Exploration of novel disease-modifying treatments and their potential application.

Conclusions:

• A specialized, multidisciplinary framework is essential for optimizing Huntington's disease care in Korea.
• Early diagnosis, proactive management of comorbidities, and personalized treatment are key to improving patient and caregiver outcomes.
• This framework supports the integration of genetic insights, biomarker research, and therapeutic advancements into clinical practice for HD in Korea.